Navigation Links
Palomar Successful in U.S. Patent Office Re-Examination of Hair Removal Patent
Date:6/15/2009

In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies, Inc., to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the Company's current expectations, plans, intentions, beliefs or predictions. These forward-looking statements are neither promises nor guarantees, but involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performance to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products and additional applications, the results of litigation, including patent infringement lawsuits, difficulties in collecting royalties, potential infringement of third-party intellectual
'/>"/>

SOURCE Palomar Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
3. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
4. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
5. Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. Palomar Medical Reports Financial Results for Third Quarter 2008
8. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
9. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
10. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
11. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...A, Israel, November 20 C...tp://www.CVSLMEDICAL.COM , a leading,developer of ...announced that,the company,s Board of Directors ha...e, Canada and the Far East for its proprietary nex...all angioplasty (PCTA) procedures. , Card...
(Date:11/20/2009)...ed online November 20 in the Journal of the Natio...ars and hopes that often appear in news coverage o... for both the media and journals to help alleviate...d Steven Woloshin, M.D., M.S., of Center for Medic...ealth Policy and Clinical Practice in New Hampshir...
(Date:11/20/2009)... Based out of Dallas, TX, the new addition to b...ts that are made in the USA. , ... sky scrubs is an independent medical scrubs brand...roduction and distribution of hospital uniforms an...ir products via their online boutique, the Austin,...
(Date:11/20/2009)...ins high and is expected to continue, CDC says, ,...ome areas of the United States are seeing declines...cial said Friday, and while the disease remains wi...tes reported last week. , "We are beginning to ... country, but there is still a lot of influenza ev...
(Date:11/20/2009)... VIEW, Calif., Nov. 20 O...of system solutions to acute healthcare facilities... 21st Annual Piper Jaffray Healthcare Conference ..., Omnicell Speakers: Randall A. Lipps, founder, ...resident & CFO ,, Date: Tuesday, December...
Breaking Medicine News(10 mins):Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...s from the Case Western Reserve University School ...cine identified a novel therapeutic that reduces s...n the June issue of the Journal of Leukocyte Biol... haze, corneal thickening and inflammation. These ...
...e NSAIDS, it could prevent buildup of plaque in th... (HealthDay News) -- A class of drugs called gamma... Alzheimer,s disease, a new study suggests. , A ha...ieces of amyloid beta protein that stick together ...
...nce, Wednesday June 11th 2008: At least 50% of rec...mission (a state free of signs and symptoms) withi... step-up DMARD treatment in combination with tight...e. Results of this study indicate that achieving r...
...ATION June 11, 2008 Understanding the way bacteri...ffective methods for fighting the often persistent...y form, says a Texas A&M University professor of c...ria widely considered a model organism for microb...
...lls provide early diagnosis; diet could affect ch...HealthDay News) -- Subtle changes in the DNA,s che...o cancer by making the cells addicted to turning t...e of the British Journal of Cancer , are now look...
...rents are to be quizzed about their children,s sex... the way the subject is taught to deaf pupils. , ...ess team is recruiting parents of both deaf and he...E more accessible for deaf children and, at a late...
Other Medicine News:Health News:New Class of Drugs May Fight Alzheimer's 2Health News:New Class of Drugs May Fight Alzheimer's 3Health News:50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks 2Health News:Chemical engineering researchers identify biofilms that cause infections 2Health News:Chemical engineering researchers identify biofilms that cause infections 3Health News:Chemical engineering researchers identify biofilms that cause infections 4Health News:DNA Coding May Make Bowel Prone to Cancer 2Health News:Study aims to improve sex education for deaf pupils 2Health News:Study aims to improve sex education for deaf pupils 3
(Date:11/19/2009)... , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-First...BCRX ) today announced the pricing of a public off...9.75 per share, resulting in gross proceeds of $48...by BioCryst pursuant to an effective shelf registr...es and Exchange Commission. BioCryst has also gra...
(Date:11/19/2009)..., DAYTON, Ohio, Nov. 19 Riverain...partnering with leading Canadian medical imaging d...ed Chest Imaging and OnGuard Chest Xray CAD. The e...iverain Medical,s products to the Canadian market ... sales channel. ,, SoftView Enhanced Chest Imag...
(Date:11/19/2009)... , SCHAUMBERG, Ill., Nov. 19 ...e, PACS-neutral healthcare image management soluti...nt to provide a combined PACS- neutral archive sol..., Data Distributing, an international leader in pr...olutions to the medical industry. Under the agree...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2AGU journal highlights Aug 6 2009 9508 1AGU journal highlights Aug 6 2009 9508 2AGU journal highlights Aug 6 2009 9508 3AGU journal highlights Aug 6 2009 9508 4AGU journal highlights Aug 6 2009 9508 5AGU journal highlights Aug 6 2009 9508 6AGU journal highlights Aug 6 2009 9508 7AGU journal highlights Aug 6 2009 9508 8AGU journal highlights Aug 6 2009 9508 9AGU journal highlights Aug 6 2009 9508 10AGU journal highlights Aug 6 2009 9508 11AGU journal highlights Aug 6 2009 9508 12AGU journal highlights Aug 6 2009 9508 13Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 53885 1Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 53885 2Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 53885 3Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 53885 4
...N.C.--(BUSINESS WIRE)--Apr 3, 2007 -,Icagen, Inc. ...anned meeting of the independent Data Monitoring C...senicapoc (formerly,ICA-17043) for the treatment o...ed that the trial be terminated because of the low...te, the primary,endpoint. In making their recommen...
...il 04, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc....the,mechanism of action and role of NU206 (R-Spond...strointestinal (GI) epithelial cells,will be prese...n,Association for Cancer Research (AACR) Annual Me...enter in Los Angeles, CA, April,14-18, 2007. , , ...
Other Medicine Technology:Icagen Terminates Phase III ASSERT Study 2Icagen Terminates Phase III ASSERT Study 3Nuvelo Announces Presentation on NU206 at 2007 American Association,for Cancer Research Annual Meeting 2Nuvelo Announces Presentation on NU206 at 2007 American Association,for Cancer Research Annual Meeting 3Nuvelo Announces Presentation on NU206 at 2007 American Association,for Cancer Research Annual Meeting 4
Bravo pH System (catheter free pH testing)
... system utilizing state of the art technology. 51...surements over a 24-hour period or longer. Progra... Powerful Microsoft Windows compatible software f...asy to configure & hook-up. 1 year warranty + lif...
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin
...noassay for the ,quantitative determination of a...man serum using the coated tube technique. ,For ...ively ,enzymatic active native TPO from human th...bodies older methods use as antigen ,denaturated...
Medicine Products: